What SERVImed Industrial does

SERVImed Industrial is a privately held Italian medical device company founded in 2011 and headquartered in Rome, operating as an R&D, manufacturing, and distribution platform for ophthalmic and general surgery devices. The company's commercial core is built on its 2014 partnership with Iromed Group, under which SERVImed acts as the exclusive worldwide distributor of Iromed's patented ophthalmic product line. The portfolio spans corneal cross-linking solutions (RIBOCROSS te and RIBOFAST, both leveraging Vitamin E TPGS as a penetration enhancer), the CF X-LINKER UV device with proprietary Custom Fast CXL (cfCXL) protocol software, ophthalmic eye drops (DROP defence, the first PPE-certified anti-UV/blue-light eye drop, plus DROP therapeutic, DROPsept, DROPclar, DROPtonic 5%, and the Ribohyal new chemical entity gel), diagnostic and surgical stains (REmark, REmark C, REmark VTR-VM), viscoelastics (Viscorib), and the HEMOdiss bipolar radiofrequency surgical system for hemostasis. The company also distributes BD/BARD product lines in Italy and offers Global Service infection prevention and OR management services to healthcare facilities.

SERVImed generates revenue primarily through hardware sales and consumables distribution, monetized via direct field sales, an enterprise sales motion, and a global network of distribution partners reaching 60+ countries across Europe, Middle East, Africa, Asia Pacific, and the Americas. Customer segments are horizontal in design, spanning ophthalmologists and corneal specialists (primary), general/thoracic/orthopedic surgeons (HEMOdiss), and public/private healthcare facilities (medical devices plus Global Service). The company markets through industry congresses, scientific publications, and direct clinical engagement. It also holds minority equity stakes in six affiliated Italian startups covering urology/gynecology (NextMed, EFG Medical), cardiac anesthesia (Viscop), general surgery (Kylix), and cardiac surgery R&D (StaRTRIC), functioning as a small incubator-style group.

The competitive position rests on a defensible IP and regulatory stack: international patents on most formulations, CE marking across the catalog, and unique PPE certification for DROP defence. The CF X-LINKER/RIBOCROSS-RIBOFAST stack is structurally tied through the cfCXL protocol, creating a system-level switching cost for adopters. Founded by Francesco Napolitano, the company has no disclosed institutional investors, no public listing, no funding rounds in the source data, and no disclosed revenue or headcount growth metrics, limiting financial visibility. Key forward catalysts include FDA entry via the 2019 TECLens partnership, continued APAC expansion post-China launch, and portfolio broadening into vitreoretinal surgery and viscoelastics.

Name

SERVImed Industrial

Legal name

SERVImed Industrial S.r.l.

Website

https://servimed-industrial.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

SERVImed Industrial is a privately held Rome-based medical device company that distributes patented ophthalmic products (corneal cross-linking solutions, UV devices, eye drops, surgical stains) and surgical radiofrequency systems worldwide through exclusive partnerships with Iromed Group and HEMOdiss, serving ophthalmologists and hospitals across 60+ countries.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Ophthalmic Goods Manufacturing (339115), Ophthalmic Goods Merchant Wholesalers (423460), Surgical and Medical Instrument Manufacturing (339112)

SIC

Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF)

akta.pro secondary industries

Dry Eye & Ocular Surface Devices (Meibography, Tear Osmolarity, IPL, Thermal Pulsation) (HLAHAJAF), Ophthalmology Pharmaceuticals (HLAIAAAL), Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets) (HLAHADAL)

Keywords

• Ophthalmic medical devices
• Corneal cross-linking solutions
• Ophthalmic surgical instruments
• Eye drops and solutions
• Medical device distribution

Headquarters

HQ city

Rome

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations, Infrastructure

Revenue model

1. Ophthalmic Medical Devices Distribution: SERVImed Industrial distributes ophthalmic medical devices globally through partnerships with Iromed Group and other manufacturers. Revenue comes from distribution of patented ophthalmic products including cross-linking solutions, UV devices, eye drops, and diagnostic solutions.
2. Medical Devices Distribution: Italian distribution of medical devices by leading global manufacturers, including BD/BARD products. Revenue from distribution of general surgery and urology/gynecology medical devices.
3. Global Service for Healthcare Facilities: Global Service, infection prevention, control & management services to public and private healthcare structures. Includes setting up and managing hospital rooms and wards based on maximum efficiency.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

SERVImed Industrial is an Italian medical device company engaged in R&D, manufacturing, and worldwide distribution of ophthalmic and general surgery medical devices. Its product portfolio spans corneal cross-linking solutions (RIBOCROSS te, RIBOFAST), UV cross-linking devices (CF X-LINKER), ophthalmic eye drops (DROP defence, DROP therapeutic, DROPsept, DROPclar, DROPtonic 5%, Ribohyal), surgical staining solutions (REmark, REmark C, REmark VTR-VM), dietary supplements (MACUoff, CLARvision), and bipolar surgical radiofrequency systems (HEMOdiss). The company also distributes BD/BARD products in Italy and provides Global Service infection prevention and management services to healthcare facilities.

Product overview

SERVImed Industrial is an R&D, manufacturing, and distribution company for ophthalmic and general surgery medical devices. The company operates through distinct product lines: (1) Ophthalmic Surgical Line featuring CF X-LINKER UV device, RIBOCROSS te and RIBOFAST riboflavin cross-linking solutions, and REmark surgical stains (VTR-VM for vitreoretinal surgery, C for anterior chamber); (2) Ophthalmic Eye Drops including DROP defence (PPE-certified anti-UV), DROP therapeutic, DROPsept, DROPclar, DROPtonic 5%, and Ribohyal gel; (3) Diagnostics with REmark riboflavin-based diagnostic solution; (4) Dietary Supplements including MACUoff and CLARvision; (5) Surgical Radiofrequency with HEMOdiss system (HG1 generator and surgical sealers). The company serves healthcare facilities worldwide through distribution networks across Europe, Middle East, Africa, Asia Pacific, and America.

Differentiator

Problem solved

Functional benefit

Brands

• RIBOCROSS te: Patented ophthalmic solution for corneal cross-linking, based on riboflavin and Vitamin E TPGS. Fit for every CXL protocol and the only solution using Vitamin E TPGS enhancing properties.
• CF X-LINKER
• RIBOFAST
• DROP defence
• DROP therapeutic
• DROPsept
• DROPclar
• DROPtonic 5%
• Ribohyal
• REmark
• REmark C
• REmark VTR-VM
• MACUoff
• CLARvision
• HEMOdiss

Products and services

• CF X-LINKER UV device for corneal cross-linking with a 10-inch touchscreen, integrated camera, and proprietary software that performs Custom Fast CXL (cfCXL), a customized low power EPI-ON protocol. Designed for ophthalmologists and corneal specialists treating keratoconus and corneal ectasias.
• RIBOCROSS te Patented ophthalmic solution for corneal cross-linking with 10% Dextran, using Vitamin E TPGS as penetration enhancer. Compatible with every CXL protocol and UV device; intended for ophthalmologists performing corneal cross-linking procedures.
• RIBOFAST Patented dextran-free ophthalmic solution for corneal cross-linking, using Vitamin E TPGS as penetration enhancer. Compatible with every CXL protocol and Custom Fast CXL; intended for ophthalmologists.
• REmark Patented riboflavin-based diagnostic solution that serves as an alternative to fluorescein for tonometry and ocular surface diagnosis via tear film staining. Has approximately 10x longer permanence on ocular surface compared to fluorescein. Available in multidose and single-dose formats.
• REmark C Sterile surgical staining solution for anterior capsule staining during cataract surgery, glaucoma surgery, and corneal transplants. For ophthalmic surgeons.
• REmark VTR-VM Sterile solution for ocular surface indicated for vitreoretinal surgery, particularly vitreous staining, Proliferative Diabetic Retinopathy, and tractional retinal detachments. For vitreoretinal surgeons.
• DROP defence Patented ophthalmic solution based on Vitamin B2 (Riboflavin), Vitamin E TPGS, MSM, amino acids, and Sodium Hyaluronate 0.1%. First and only PPE-certified eye drop with anti-UV and anti-blue light shielding effect for ocular surface protection.
• DROP therapeutic Ophthalmic solution based on Vitamin B2, Vitamin E TPGS, Sodium Hyaluronate, and amino acids with protective action on corneal epithelium and natural repairing processes. Indicated for dry eye, cross-linking patients, and keratoconus.
• DROPsept

Quantifiable outcome

• 7-year clinical follow-up published for Custom Fast CXL EPI-ON procedure

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Iromed Group S.r.l.coreChannel Partner/ Reseller/ Distributor · 1 January 2014Partnership launched in 2014 for the Ophthalmic division. Iromed Group researches, develops, and manufactures unique and innovative eye care products, and SERVImed Industrial commercializes them worldwide. All ophthalmic products commercialized by SERVImed Industrial are patented and supported by international publications.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Sooft Italia: Italian ophthalmic pharmaceutical and medical device company specializing in ocular surface, dry eye, and corneal products, directly comparable to SERVImed's DROP line and Ribohyal gel for dry eye and ocular surface care.
• Heidelberg Engineering: Specialized ophthalmic diagnostic imaging company whose ocular surface and anterior segment diagnostics are directly comparable to SERVImed's REmark riboflavin-based ocular surface diagnosis solution.
• Ziemer Ophthalmic Systems: Swiss manufacturer of UV cross-linking devices (CXL-365) and ophthalmic surgical equipment, a direct competitor in the corneal cross-linking device and riboflavin solution space served by SERVImed.
• Glaukos (Avedro): Glaukos acquired Avedro in 2019, making it the dominant player in corneal cross-linking (Photrexa Vibe/CXL) directly competing with SERVImed's RIBOCROSS te/RIBOFAST and CF X-LINKER platform for keratoconus and ectasia treatment.

Emerging players

• Eyedetec Medical: Emerging ophthalmic medical device company developing drug-delivery and diagnostic ophthalmic products; comparable as a smaller, focused ophthalmic device/solutions player in adjacent niche categories to SERVImed.

Broad incumbents

• Alcon: World's largest eye-care device and pharmaceutical company, competing in cataract surgery devices, ophthalmic solutions, and surgical stains where SERVImed's REmark C and REmark VTR-VM are positioned.
• Nidek Co., Ltd. Japanese ophthalmic and optometric equipment manufacturer offering diagnostic, surgical, and refractive devices, comparable to SERVImed's CF X-LINKER UV device and broader ophthalmic device portfolio.
• Topcon Healthcare: Established ophthalmic diagnostic and surgical device manufacturer with global distribution comparable to SERVImed's model of distributing Iromed Group devices and solutions worldwide.
• Carl Zeiss Meditec: Global broad-line ophthalmic medical device incumbent with diagnostic, surgical, and laser platforms. Comparable as a large ophthalmic device portfolio player against SERVImed's specialized ophthalmic solutions and devices.
• Bausch + Lomb: Major ophthalmic pharmaceuticals and devices company with broad dry-eye, cataract, and surgical portfolios that overlap with SERVImed's DROP and Ribohyal product lines and surgical staining franchise.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/servimed-industrial-spa

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SERVImed Industrial